GENSCRIPT BIO(01548): CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026
GENSCRIPT BIO (01548) announced that, pursuant to the Collaboration and License Agreement entered into on December 21, 2017 between Legend Biotech Corporation (an associate of the Company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) and Janssen Biotech, Inc. (Janssen), CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026.
GENSCRIPT BIO(01548) announced that, pursuant to the Collaboration and License Agreement entered into on December 21, 2017 between Legend Biotech Corporation (an associate of the Company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) and Janssen Biotech, Inc. (Janssen), CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026.
Related Articles
SEM HLDGS (09929) recorded revenue of approximately HK$346 million in the first three quarters.
AKESO (09926) proposes to place a total of 20 million placing shares, raising approximately HK$1.941 billion net.
A-share IPO | Water purification component supplier Yuanda Jianke (920285.BJ) opens subscription, multiple products consistently rank on Amazon's best-selling lists for water filtration and pool filter cartridges.
SEM HLDGS (09929) recorded revenue of approximately HK$346 million in the first three quarters.
AKESO (09926) proposes to place a total of 20 million placing shares, raising approximately HK$1.941 billion net.
A-share IPO | Water purification component supplier Yuanda Jianke (920285.BJ) opens subscription, multiple products consistently rank on Amazon's best-selling lists for water filtration and pool filter cartridges.
